The use of high-throughput sequencing has allowed us to gain more insight into the molecular mechanisms of ENKTCL, which largely involves chromosome deletion and aberrations in the JAK/STAT and PD-1/PD-L1 pathways, as well as mutations in tumor suppressor genes. The gene discussed is SOAT1; the disease is neoplasm.